AbstractTrimers of the HIV-1 envelope glycoprotein (Env) effectuate viral entry into susceptible cells. Therefore Env trimers are the targets for neutralizing antibodies. This study models the number of trimers required for virion infectivity. It also delineates the minimum number of antibody molecules that would neutralize a virion. First, Env function was assumed to be incremental (all envelope glycoprotein units contribute equally) or liminal (characterized by thresholds). Then, such models were combined and shown to fit published data on phenotypically mixed pseudotype viruses. Virions with 9 trimers would require around a median of 5 of them for strong infectivity; the proportion varies among strains and mutants. In addition, the model...
Abstract An effective HIV-1 vaccine probably will need to be able to induce broadly neutralizing HIV...
An effective HIV-1 vaccine probably will need to be able to induce broadly neutralizing HIV-1 antibo...
AbstractThe native, functional HIV-1 envelope glycoprotein (Env) complex is a trimer of two non-cova...
AbstractTrimers of the HIV-1 envelope glycoprotein (Env) effectuate viral entry into susceptible cel...
AbstractEndoproteolytic processing of the human immunodeficiency virus type 1 (HIV-1) envelope (Env)...
SummaryEfforts to prevent human immunodeficiency virus type 1 (HIV-1) infection would benefit from u...
AbstractInsights into the process of HIV-1 neutralization may assist rational vaccine design. Here, ...
HIV-1 envelope proteins (Envs) play a critical role in HIV infection. In a correct trimeric conforma...
AbstractThe human immunodeficiency virus type 1 (HIV-1) envelope (Env) glycoprotein forms trimers th...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
AbstractHuman immunodeficiency virus type 1 (HIV-1) entry into host cells is mediated by the trimeri...
AbstractA critical component of an effective HIV vaccine will be the induction of broadly neutralizi...
HIV-1 has evolved various tricks to prevent the development of a potent humoral immune response. The...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
AbstractThe human immunodeficiency virus type 1 (HIV-1) envelope protein (Env) has evolved to limit ...
Abstract An effective HIV-1 vaccine probably will need to be able to induce broadly neutralizing HIV...
An effective HIV-1 vaccine probably will need to be able to induce broadly neutralizing HIV-1 antibo...
AbstractThe native, functional HIV-1 envelope glycoprotein (Env) complex is a trimer of two non-cova...
AbstractTrimers of the HIV-1 envelope glycoprotein (Env) effectuate viral entry into susceptible cel...
AbstractEndoproteolytic processing of the human immunodeficiency virus type 1 (HIV-1) envelope (Env)...
SummaryEfforts to prevent human immunodeficiency virus type 1 (HIV-1) infection would benefit from u...
AbstractInsights into the process of HIV-1 neutralization may assist rational vaccine design. Here, ...
HIV-1 envelope proteins (Envs) play a critical role in HIV infection. In a correct trimeric conforma...
AbstractThe human immunodeficiency virus type 1 (HIV-1) envelope (Env) glycoprotein forms trimers th...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
AbstractHuman immunodeficiency virus type 1 (HIV-1) entry into host cells is mediated by the trimeri...
AbstractA critical component of an effective HIV vaccine will be the induction of broadly neutralizi...
HIV-1 has evolved various tricks to prevent the development of a potent humoral immune response. The...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
AbstractThe human immunodeficiency virus type 1 (HIV-1) envelope protein (Env) has evolved to limit ...
Abstract An effective HIV-1 vaccine probably will need to be able to induce broadly neutralizing HIV...
An effective HIV-1 vaccine probably will need to be able to induce broadly neutralizing HIV-1 antibo...
AbstractThe native, functional HIV-1 envelope glycoprotein (Env) complex is a trimer of two non-cova...